Skip to content
Business Company News, Medical Health Aged Care

Servatus confirms the appointment of Mark Williams as CEO

Servatus Limited 2 mins read
Mark Williams, Servatus CEO

Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, is pleased to announce the appointment of Mr Mark Williams as Chief Executive Officer.

First joining Servatus as a Non-Executive Director in February 2018, Mr Williams was appointed Chief Financial Officer and Executive Director in July 2018. Prior to joining Servatus, he had a long and successful career in investment banking, spending two decades with Macquarie Bank in senior roles in Sydney, London, and South America, ultimately leading Macquarie in Brazil. 

Mr Williams said he was deeply honoured to step into the CEO role at Servatus and build upon the legacy of Dr Wayne Finlayson, the Company’s Co-founder and CEO who passed away in September. “Wayne was a visionary and I am proud to build upon his ground-breaking work in microbiome-based therapeutics.” 

“Servatus is an exciting and dynamic business, with significant developments underway across our clinical program and our over-the-counter consumer products business, biomiq. We have several key inflection points over the coming 12 months that I’m confident will further cement our position as a leading microbiome-based therapeutics company globally.”

Servatus is progressing its comprehensive clinical program for its live biotherapeutics. Currently four clinical trials are in progress for insomnia, IBS-C, Helicobacter Pylori and Rheumatoid Arthritis, with a number of important data readouts expected in H1 2024.

Additionally, Servatus’ new biomiq skincare range expands Servatus’ biomiq product portfolio, which already includes a range of powdered OTC TGA-listed biotherapeutics that target specific health complaints, including constipation and bloating.

About us:

About Servatus |


Servatus Ltd is an unlisted public biopharmaceutical company focused on creating safe, effective, and reliable microbiome-based therapeutic drugs to treat several chronic and debilitating autoimmune diseases, as well as non-antibiotic treatments for bacterial infections.  


In addition to drug research and development, and ongoing clinical trials, Servatus also owns a state-of-the-art production facility. This facility means Servatus is able to oversee all aspects of the research development and production pipeline and ensure that its live microbial biotherapeutic drug candidates are made to the highest-standard and specifications, and removes the logistical uncertainty often associated with outsourcing manufacturing.

Contact details:


For further information please contact:

Jack McLintock

+61 450 608 022 


More from this category

  • Medical Health Aged Care
  • 07/12/2023
  • 13:30
Royal Australian College of GPs and Australian College of Rural and Remote Medicine

Public consultation on Rural Generalist Medicine recognition closes next Tuesday

With less than one week to go until the public consultation closes on recognition of Rural Generalist Medicine (RGM) as a specialist field, Australia’s two GP colleges urge doctors and community members to have their say. The Australian College of Rural and Remote Medicine (ACRRM) and the Royal Australian College of General Practitioners (RACGP) are buoyed by the conversation that has been generated on the recognition of RGM throughout the process. ACRRM President Dr Dan Halliday says it has been wonderful to see the engagement through the recent webinars hosted by the Rural Generalist Taskforce, through College channels and at…

  • Contains:
  • Medical Health Aged Care, Science
  • 07/12/2023
  • 13:26
The Florey

Researchers identify neurons in the brain that control nasofacial muscles during breathing

Whilst most of us consider breathing a relatively simple process, it actually requires complex coordination of many muscles to enable airflow into and out of the lungs and to control airflow to allow us to talk, eat, and drink. Breathing also influences other related brain functions, such as emotional state, sense of smell, blood pressure, and heart rate. Breathing is generated in a brain region called Pre-Bötzinger complex (preBötC), which is composed of many subgroups of neurons that are breathing and non-breathing related. Up to now, due to technical limitations, it was almost impossible to specifically silence a subgroup of…

  • Medical Health Aged Care
  • 07/12/2023
  • 13:19
Royal Australian College of GPs

GPs vital to improving National Disability Insurance Scheme

The Royal Australian College of GPs (RACGP) has welcomed the final National Disability Insurance Scheme report and reiterated calls for GPs to be better utilised. It comes following the release today of the final report into the scheme. RACGP President Dr Nicole Higgins said that GPs must be front and centre. “It is concerning that the report doesn’t deeply delve into healthcare for people with a disability, including general practice care,” she said. “The Government must recognise that GPs play a vital role in disability care, and barriers do exist. For example, there is no Medicare patient rebate for NDIS…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.